Stock 2070 SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation

Equities

2070

SA0007879188

End-of-day quote Saudi Arabian S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
37.3 SAR +2.19% Intraday chart for Saudi Pharmaceutical Industries and Medical Appliances Corporation -1.45% -1.32%
01/04 Saudi Pharmaceutical Industries And Medical Appliances Plans Not to Distribute FY23 Dividends MT
31/03 Saudi Pharmaceutical Industries And Medical Appliances Logs Narrower FY23 Net Loss; Revenue Up MT

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • With an expected P/E ratio at 50.52 and 28.88 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION Stock Saudi Pharmaceutical Industries and Medical Appliances Corporation
-1.32% 1.2B -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.68% 699B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.35% 364B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.65% 326B
B-
ABBVIE INC. Stock AbbVie Inc.
+3.77% 286B
C+
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
B+
NOVARTIS AG Stock Novartis AG
+4.71% 198B
B-
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
A+
PFIZER, INC. Stock Pfizer, Inc.
-3.79% 154B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2070 Stock
  4. Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation